HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Shimazaki Selected Research

5- hydroxy- 6- (2- keto- 3- thiopropionyl)- 7,9,11,14- eicosatetraenoic acid

6/2001Early relapse after high-dose chemotherapy rescued by tumor-free autologous peripheral blood stem cells in acute lymphoblastic leukemia: importance of monitoring for WT1-mRNA quantitatively.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Shimazaki Research Topics

Disease

5Leukemia
05/2005 - 08/2000
5Lymphoma (Lymphomas)
11/2001 - 06/2000
4Multiple Myeloma
11/2011 - 06/2000
4Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2005 - 06/2000
3B-Cell Lymphoma (Lymphoma, B Cell)
03/2006 - 02/2001
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2002 - 08/2000
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2001 - 02/2001
3Neoplasms (Cancer)
06/2001 - 02/2001
2Residual Neoplasm
03/2005 - 06/2001
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2002 - 10/2000
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2000 - 08/2000
1Bronchiolitis Obliterans Syndrome
01/2006
1Hematologic Neoplasms (Hematological Malignancy)
02/2004
1Edema (Dropsy)
04/2003
1Graft vs Host Disease (Graft-Versus-Host Disease)
12/2002
1Acute Promyelocytic Leukemia
06/2002
1Mydriasis
06/2002
1Infections
10/2001
1Cholesteatoma
10/2001
1Primary Effusion Lymphoma
10/2001
1MYH9-Related Disorders
10/2001
1Philadelphia Chromosome
02/2001
1Pancytopenia
02/2001
1Ovarian Neoplasms (Ovarian Cancer)
02/2001
1Myeloid Leukemia (Leukemia, Myelocytic)
02/2001
1monosomy Chromosome 7
02/2001
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
02/2001
1Chromosome Aberrations (Chromosome Abnormalities)
08/2000
1Pathologic Complete Response
06/2000

Drug/Important Bio-Agent (IBA)

2Dexamethasone (Maxidex)FDA LinkGeneric
06/2008 - 06/2000
2Rituximab (Mabthera)FDA Link
03/2006 - 01/2006
2Oxidoreductases (Dehydrogenase)IBA
02/2002 - 10/2000
2quinone (benzoquinone)IBA
02/2002 - 10/2000
2NAD (NADH)IBA
02/2002 - 10/2000
2Glutathione (Reduced Glutathione)IBA
02/2002 - 10/2000
2Tumor Viral Antigens (Large T Antigen)IBA
11/2001 - 06/2000
2AntigensIBA
11/2001 - 06/2000
2Interferon-alpha (Interferon Alfa)IBA
08/2001 - 06/2000
2Etoposide (VP 16)FDA LinkGeneric
02/2001 - 10/2000
1CateninsIBA
11/2011
1Thalidomide (Thalomid)FDA Link
06/2008
1SteroidsIBA
01/2006
1Bortezomib (Velcade)FDA Link
06/2005
1Alkaline PhosphataseIBA
06/2005
1Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
03/2005
1Imatinib Mesylate (Gleevec)FDA Link
04/2003
1Methotrexate (Mexate)FDA LinkGeneric
12/2002
1Tacrolimus (Prograf)FDA LinkGeneric
12/2002
1Vindesine (Vindesin)IBA
06/2002
1Pharmaceutical PreparationsIBA
02/2002
1glutathione S-transferase T1IBA
02/2002
1Glutathione Transferase (Glutathione S-Transferase)IBA
02/2002
1Peroxidase (Myeloperoxidase)IBA
02/2002
1HLA-DR Antigens (HLA-DR)IBA
10/2001
1Thrombopoietin (c-mpl Ligand)IBA
10/2001
1Nuclear Antigens (Extractable Nuclear Antigens)IBA
10/2001
1ParaffinIBA
09/2001
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
06/2001
15- hydroxy- 6- (2- keto- 3- thiopropionyl)- 7,9,11,14- eicosatetraenoic acidIBA
06/2001
1Messenger RNA (mRNA)IBA
06/2001
1Phosphotransferases (Kinase)IBA
04/2001
1tyrosine receptor (receptor, tyrosine)IBA
04/2001
1PlatinumIBA
02/2001
1Carboplatin (JM8)FDA LinkGeneric
02/2001
1Cytarabine (Cytosar-U)FDA LinkGeneric
02/2001
1EnzymesIBA
10/2000
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10/2000
1Cytochrome P-450 CYP3AIBA
10/2000
1Hydroxyurea (Hydrea)FDA LinkGeneric
08/2000
1InterferonsIBA
08/2000
1Melphalan (Alkeran)FDA LinkGeneric
06/2000
1B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA
06/2000
1Vincristine (Oncovin)FDA LinkGeneric
06/2000
1ranimustineIBA
06/2000

Therapy/Procedure

5Drug Therapy (Chemotherapy)
03/2006 - 06/2000
5Therapeutics
06/2005 - 06/2000
3Transplantation
03/2005 - 06/2001
3Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
02/2004 - 06/2000
2Bone Marrow Transplantation (Transplantation, Bone Marrow)
10/2001 - 08/2001
2Combination Drug Therapy (Combination Chemotherapy)
08/2000 - 06/2000
1Stem Cell Transplantation
05/2005
1Hematopoietic Stem Cell Transplantation
12/2002
1Ventriculoperitoneal Shunt
10/2001
1Debridement
10/2001
1Autologous Transplantation
08/2000